Launch of the Get Personal Campaign on World Metastatic Colorectal Cancer Day
27 September 2016 is World Metastatic Colorectal Cancer Day. A day dedicated to raise awareness of the most advanced form of colorectal cancer, known as metastatic colorectal cancer or advanced bowel cancer. This is when the cancer has spread to other parts of the body, such as the liver or lungs.
Each year there are 1.4 million new cases and 694,000 deaths from colorectal cancer. Many of these deaths are caused because the disease is detected too late. Approximately 20% of people across Europe and the US are diagnosed when the cancer has spread and even more go on to develop metastatic colorectal cancer after having been diagnosed at an earlier stage. Here in the UK nearly 4,000 people are diagnosed with advanced bowel cancer each year. Regardless of where you live in the world, people diagnosed with metastatic colorectal cancer have no more than a 1 in 10 chance of surviving more than five years.
However, with timely access to effective treatment and high quality care, people with metastatic disease can see their survival chances and their quality of life dramatically improve. But for too many patients, access to treatment is dependent on whether they have adequate insurance or if their public health system has approved specific treatments, rather than what their doctors and healthcare providers believe would benefit them most.
To coincide with this important day, Bowel Cancer UK, Bowel Cancer Australia, Colon Cancer Alliance (US), Colorectal Cancer Association of Canada, and Fondation A.R.CA.D. (France), have come together to launch the global Get Personal Campaign to make real change happen for people with advanced colorectal cancer.
Get Personal aims to increase survival rates, improve quality of life and reduce variation in access to best treatment and care for people living with metastatic colorectal cancer around the world.
Get Personal is committed to:
- Eliminating variation between and within countries so that everyone, irrespective of where they live, has access to the best treatment and care.
- Putting metastatic colorectal cancer firmly on the agenda of governments, health care providers and key decision-makers.
- Campaigning for further research to address gaps in knowledge and support the development of new, innovative and effective treatments.
- Raising awareness among patients, clinicians and policy-makers of the full range of tests and treatments to be made available.
For more information on the campaign and to find out how more about Bowel Cancer UK visit www.bowelcanceruk.org.uk